Anxiolytic-like effects of the selective metabotropic glutamate receptor 5 antagonist MPEP after its intra-amygdaloid microinjection in three different non-conditioned rat models of anxiety

European Journal of Neuroscience

Volumn 23, Issue 10, 2006, Pages 2749-2759

  De La Mora, Miguel Pérez ^a   Lara García, Daniel ^a   Jacobsen, Kirsten X ^b   Vázquez García, Mariana ^a   Crespo Ramírez, Minerva ^a   Flores Gracia, Candy ^a   Escamilla Marvan, Edgardo ^c   Fuxe, Kjell ^d  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSITY OF OTTAWA   (Canada)

^c INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Amygdala; Anxiety; Behavior; Dopamine; Glutamate; Intercalated islands

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; EVALUATION; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; EXPERIMENTAL TEST; EXPLORATORY BEHAVIOR; FUNCTION TEST; LATENT PERIOD; MALE; MAZE TEST; MICROINJECTION; NEUROMODULATION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SHOCK PROBE BURYING TEST; STATISTICAL SIGNIFICANCE; TRANQUILIZING ACTIVITY; WHITE AND BLACK BOX TEST;

AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CONDITIONING, CLASSICAL; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; MICROINJECTIONS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 33744479993     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.04798.x     Document Type: Article

References (50)

1. Brodkin, J., Bradbury, M., Busse, C., Warren, N., Bristow, L.J. Varney, M.A. 2002a Reduced stress-induced hyperthermia in mGluR5 knockout mice. Eur. J. Neurosci., 16, 2241 2244.
2. Brodkin, J., Busse, C., Sukoff, S.J. Varney, M.A. 2002b Anxiolytic like activity of the mGluR5 antagonist MPEP: a comparison with diazepam and buspirone. Pharmacol. Biochem. Behav., 73, 359 366.
3. Calabresi, P., Centozone, D., Gubellini, P., Marfia, G.A., Pisan, A., Sancesario, G. Bernardi, G. 2000 Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog. Neurobiol., 61, 231 265.
4. Chaouloff, F., Durand, M. Mormède, P. 1997 Anxiety- and activity-related effects of diazepam and chlorodiazepoxide in rat light/dark and dark/light test. Behav. Brain Res., 85, 27 35.
5. Chen, S. Buckmaster, P.S. 2005 Stereological analysis of forebrain regions in kainate-treated epileptic rats. Brain Res., 1057, 141 152.
6. Conn, P.J. Pin, J.P. 1997 Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol., 37, 205 237.
7. Costall, B., Jones, B.J., Kelly, M.E., Naylor, R.J. Tomkins, D.M. 1989 Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol. Biochem. Behav., 32, 777 785.
8. Davis, M. Whalen, P.J. 2001 The amygdala: vigilance and emotion. Mol. Psych., 6, 13 34.
9. Dunn, O.J. 1964 Multiple contrast using rank sums. Technometrics, 6, 241 252.
10. Fendt, M. Schmid, S. 2002 Metabotropic glutamate receptors are involved in amygdaloid plasticity. Eur. J. Neurosci., 15, 1535 1541.
11. Fernández-Guasti, A., Ferreira, A. Picazo, O. 2001 Diazepam but not buspirone, induces similar anxiolytic-like effects in lactating and ovariectomized Wistar rats. Pharmacol. Biochem. Behav., 70, 85 93.
12. Fuxe, K., Jacobsen, K.A., Höistad, M., Tinner, B., Jansson, A., Staines, W.A. Agnati, L.M. 2003 The dopamine D1 receptor-rich main and paracapsular intercalated nerve cells groups of the rat amygdala: relationship to the dopamine inervation. Neuroscience, 119, 773 746.
13. Garcia, R., Voulmba, R.-M., Vaudry, M. Thompson, R. 1999 The amygdala modulates prefrontal cortex activity relative to conditioned fear. Nature, 402, 294 296.
14. Gasparini, F., Lingenhöhl, K., Stoehr, N., Flor, P.J., Heinrich, M., Vranesic, I., Biollaz, M., Allgieir, H., Heckendorn, R., Urwyler, S., Verney, M.A., Jhonson, E.C., Hess, S.D., Rao, S.P., Sacaan, A.I., Santori, E.M., Velicelebi, G. Kuhn, R. 1999 2-Methyl-6-(phenylethy)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology, 38, 1493 1503.
15. Henniger, M.S.H., Ohl, F., Hölter, S.M., Weißenbacher, P., Toschi, M., Lörscher, P., Wigger, A., Spanagel, R. Landgraf, R. 2000 Unconditioned anxiety and social behavior in two rat lines selectively bred for high and low anxiety-related behavior. Behav. Brain Res., 111, 153 163.
16. Hernández-Gómez, A.M., Aguilar-Roblero, R. Pérez de la Mora, M. 2002 Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety. Amino Acids, 23, 283 290.
17. Jacobsen, K.X. Staines, W.A. 2004 Vibration enhancement of slide mounted immunofluorescence staining. J. Neurosci. Methods, 137, 71 77.
18. James, T.A. Starr, M.S. 1978 Effects and the rate and volume of injection of the pharmacological response elicited by intranigral microapplication of drugs in the rat. J. Pharmacol. Methods, 1, 197 202.
19. Jansson, A., Goldstein, M., Tinner, B., Zoli, M., Meador-Woodruff, J.H. Lew, J.Y. 1999 On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat. Neuroscience, 89, 473 489.
20. LeDoux, J.E. 2000 Emotion circuits in the brain. Ann. Rev. Neurosci., 23, 155 184.
21. Marowsky, A., Möhler, H. Vogt, K.E. 2005 The paracapsular cells of the amygdala: an inhibitory network under dopaminergic control. Eur. Neuropsychopharmacol., 15, S38.
22. McDonald, A.J. Agustine, J.R. 1993 Localization of GABA-like immunoreactivity in the monkey amygdala. Neuroscience, 52, 281 294.
23. Millan, M.J. 2003 The neurobiology and control of anxious states. Prog. Neurobiol., 70, 83 244.
24. Miranda, M.I., Ferreira, G., Ramírez-Lugo, L. Bermúdez- Rattoni, F. 2002 Glutamatergic activity in the amygdala signals visceral input during taste memory formation. Proc. Natl Acad. Sci. USA, 99, 11417 11422.
25. Paquet, M. Smith, Y. 2003 Group I metabotropic glutamate receptors in the monkey striatum: subsynaptic association with glutamatergic and dopaminergic afferents. J. Neurosci., 23, 7659 7669.
26. Paré, D., Quirk, G.J. LeDoux, J.E. 2004 New vistas on amygdala networks in conditioned fear. J. Neurophysiol., 92, 1 9.
27. Paré, D., Royer, S., Smith, Y. Lang, E.J. 2003 Contextual inhibitory gating of impulse traffic in the intra-amygdaloid network. Ann. NY Acad. Sci., 985, 78 91.
28. Paré, D. Smith, Y. 1993a Distribution of GABA immunoreactivity in the amygdaloid complex of the cat. Neuroscience, 57, 1061 1076.
29. Paré, D. Smith, Y. 1993b The intercalated cell masses project to the central and medial nuclei of the amygdala in cats. Neuroscience, 57, 1977 1090.
30. Paxinos, G. Watson, C. 1998 The Rat Brain in Stereotaxical Coordinates, 4th edn. Academic Press, San Diego.
31. Pellow, S., Chopin, P., File, S.E. Briley, M. 1985 Validation of Open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods, 14, 149 167.
32. Pérez de la Mora, M., Cárdenas-Cachón, L., Vázquez-García, M., Crespo-Ramírez, M., Jacobsen, K., Höistad, M., Agnati, L. Fuxe, K. 2005 Anxiolytic effects of intra-amygdaloid injection of the D1 antagonist SCH23390 in the rat. Neurosci. Lett., 377, 101 105.
33. Peterson, S.L. 1988 Drug Microinjection Discrete Brain Regions. Kopf Carrier No. 50. David Kopf Instruments, Tujunga, California.
34. Ramos, A., Berton, O., Mormède, P. Chaouloff, F. 1997 A múltiple-test study of anxiety-related behaviors in six inbred rat strains. Behav. Brain Res., 85, 57 69.
35. Rodgers, R.J. 1997 Animal models of 'anxiety' where next? Behav. Pharmacol., 8, 477 496.
36. Rodrigues, S.M., Bauer, E.P., Farb, C.R., Schafe, G.E. LeDoux, J.E. 2002 The group I metabotropic glutamate receptor mGluR5 is required for fear memory formation and long term potentiation in the lateral amygdala. J. Neurosci., 22, 5219 5229.
37. Romano, C., Sesma, M.A., McDonald, C.T., O'Malley, K., van den Pol, A.N. Olney, J.W. 1995 Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J. Comp. Neurol., 355, 455 469.
38. Romanski, L.M. LeDoux, J.E. 1992 Equipotentiality of thalamo-amygdala and thalamo-cortico-amygdala projections as auditory conditioned stimulus pathways. J. Neurosci., 12, 4501 4509.
39. Royer, S., Martina, M. Paré, D. 1999 An inhibitory interface gates impulse traffic between the input and output stations of the amygdala. J. Neurosci., 19, 10575 10583.
40. Royer, S., Martina, M. Paré, D. 2000 Polarized synaptic interactions between intercalated neurons of the amygdala. J. Neurophysiol., 83, 3509 3518.
41. Schulz, B., Fendt, M., Gasparini, F., Lingenhöhl, Rainer, K. Koch, M. 2001 The metabotropic glutamate receptor antagonist 2-methyl-6- (phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats. Neuropharmacology, 41, 1 7.
42. Scibilia, R.J., Lachowicz, J.E. Kilts, C.D. 1992 Topographic non overlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain. Synapse, 11, 146 154.
43. Shigemoto, R., Nomura, S., Ohishi, H., Suhihara, H., Nakanishi, S. Mizuno, N. 1993 Immunohistochemical localization of a metabotropic glutamate receptor, mgluR5 in the rat brain. Neurosci. Lett., 163, 53 57.
44. Spooren, W.P.J.M., Vassout, A., Neijt, H.C., Kuhn, R., Gasparini, F., Roux, S., Porsolt, R.D. Gentsch, C. 2000 Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6- (phenylethynyl) pyridine in rodents. J. Pharmacol. Exp. Ther., 295, 1267 1275.
45. Swanson, L.W. Petrovich, G.D. 1998 What is the amygdala? Trends Neurosci., 21, 323 331.
46. Tatarczynska, E., Klodzinska, A., Chojnacka-Wojcik, E., Palucha, A., Ga, F., Kuhn, R. Pilc, A. 2001 Potential anxiolytic- and antidepressant-like effects of MPEP a potent, selective and systematically active mGlu5 receptor antagonist. Br. J. Pharmacol., 132, 1423 1430.
47. Treit, D. Menard, J. 1997 Dissociations among the ansiolytic effects of septal, hippocampal, and amygdaloid lesions. Behav. Neurosci., 111, 653 658.
48. Treit, D., Menard, J. Pesold, C. 1994 The shock-probe/burying test. Neurosci. Protocols, 94-010-02-01 - 94-010-02-09.
49. Treit, D., Pesold, C. Rotzinger, S. 1993 Noninteractive effects of diazepam and amygdaloid lesions in two animal models of anxiety. J. Neurosci., 107, 1099 1105.
50. Wieronska, J.M., Smialowska, M., Branski, M., Gasparini, F., Klodzinska, A., Szewczyk, B., Palucha, A., Chojnacka-Wojcik, E. Pilc, A. 2004 In the amygdala anxiolytic action of mGlu5 receptors antagonist MPEP involves neuropeptide Y but not GABAA signaling. Neuropsychopharmacology, 29, 514 521.